WAVE LIFE SCIENCES LTD. Effect of Exchange Rate on Cash, Continuing Operations
WAVE LIFE SCIENCES LTD. (WVE) reported Effect of Exchange Rate on Cash, Continuing Operations of $403.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashContinuingOperations · last filed 2018-03-12
- WAVE LIFE SCIENCES LTD. effect of exchange rate on cash, continuing operations for the quarter ending 2017-03-31 was $57.00K, a 307.14% increase year-over-year.
- WAVE LIFE SCIENCES LTD. effect of exchange rate on cash, continuing operations for the quarter ending 2016-03-31 was $14.00K.
- WAVE LIFE SCIENCES LTD. effect of exchange rate on cash, continuing operations for the quarter ending 2015-03-31 was -$27.00K.
- WAVE LIFE SCIENCES LTD. effect of exchange rate on cash, continuing operations for fiscal 2017 was $403.00K.
- WAVE LIFE SCIENCES LTD. effect of exchange rate on cash, continuing operations for fiscal 2016 was -$14.00K, a 193.33% decline from fiscal 2015.
- WAVE LIFE SCIENCES LTD. effect of exchange rate on cash, continuing operations for fiscal 2015 was $15.00K.
- WAVE LIFE SCIENCES LTD. effect of exchange rate on cash, continuing operations for fiscal 2014 was -$327.00K.
| Period end | Effect of Exchange Rate on Cash, Continuing Operations 3 month | Effect of Exchange Rate on Cash, Continuing Operations 6 month | Effect of Exchange Rate on Cash, Continuing Operations 9 month | Effect of Exchange Rate on Cash, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | $403.00K 10-K · filed 2018-03-12 | |||
| 2017-09-30 | $118.00K 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | $88.00K 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | $57.00K 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | -$14.00K 10-K · filed 2018-03-12 | |||
| 2016-09-30 | $101.00K 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$72.00K 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | $14.00K 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $15.00K 10-K · filed 2018-03-12 | |||
| 2015-09-30 | -$67.00K 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | -$474.00K 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | -$27.00K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | -$327.00K 10-K · filed 2017-03-16 | |||
| 2014-09-30 | -$127.00K 10-Q · filed 2015-12-17 | |||
| 2013-12-31 | -$14.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |